Rifabutin-induced cystoid macular oedema

descriptionPublicationkeyboard_double_arrow_right Article 01 Feb 2002Publisher:Oxford University Press (OUP)Journal:Journal of Antimicrobial Chemotherapy, volume 49, pages 421-422 (eissn: 1460-2091,

Copyright policy )

Authors: Vaudaux, J.D.; Guex-Crosier, Y.;

doi: 10.1093/jac/49.2.421

pmid: 11815593

Rifabutin-induced cystoid macular oedema

- Summary
- Subjects
- Metrics

Abstract

Rifabutin is a semi-synthetic antimycobacterial agent mainly used in the treatment of Mycobacterium avium-complex (MAC) in AIDS patients. Rifabutin-induced anterior uveitis has been reported previously. We report the case of a rifabutin-induced cystoid macular oedema (CMO) in an immunocompetent patient with pulmonary MAC infection. As far as we know, CMO secondary to rifabutin therapy has not been described previously.

Keywords

Pulmonary Disease, Chronic Obstructive, Rifabutin, Humans, Female, Anti-Bacterial Agents/adverse effects; Female; Humans; Macular Edema/chemically induced; Macular Edema/diagnosis; Middle Aged; Pulmonary Disease, Chronic Obstructive/drug therapy; Rifabutin/adverse effects, Middle Aged, Macular Edema, Anti-Bacterial Agents

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	19
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%